Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on May 5, 2006
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
281/18/12809    most recent
M512649200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosen, K. M.
Right arrow Articles by Querfurth, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, K. M.
Right arrow Articles by Querfurth, H. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print March 3, 2006
J. Biol. Chem, 10.1074/jbc.M512649200
Submitted on November 28, 2005
Revised on February 22, 2006
Accepted on March 3, 2006

Parkin protects against mitochondrial toxins and beta -amyloid accumulation in skeletal muscle cells

Kenneth M. Rosen, Vimal Veereshwarayya, Charbel E-H Moussa, Qinghao Fu, Matthew S. Goldberg, Michael G. Schlossmacher, Jie Shen, and Henry W. Querfurth

Neurology Dept., Caritas St. Elizabeth's Medical Center, Boston, MA 02135

Corresponding Author: kenneth_rosen{at}cchcs.org

Mutations in the ubiquitin ligase-encoding Parkin gene have been implicated in the pathogenesis of autosomal recessive Parkinson disease. Outside of the central nervous system, Parkin is prominently expressed in skeletal muscle. We have found accumulations of Parkin protein in skeletal muscle biopsies taken from patients with Inclusion Body Myositis (IBM), a degenerative disorder in which intramyofiber accumulations of the beta -amyloid peptide are pathognomonic. In comparing primary cultures of skeletal muscle derived from parkin knockout and wild-type mice, we have found the absence of parkin to result in greater sensitivity to mitochondrial stressors rotenone and carbonyl cyanide 3-chlorophenylhydrazone, without any alteration in sensitivity to calcium ionophore or hydrogen peroxide. Utilizing viral expression constructs coding for the Alzheimer’s disease and IBM-linked beta -amyloid precursor protein (beta APP) and for its metabolic byproducts Abeta 42 and C100, we find that parkin knockout muscle cells are also more sensitive to the toxic effects of intracellular Abeta . We also constructed a lentiviral system to overexpress wild-type Parkin, and show that boosting the levels of parkin expression in normal skeletal muscle cultures provides substantial protection against both mitochondrial toxins and overexpressed beta -amyloid. Correspondingly, exogenous Parkin significantly lowered Abeta levels. These data support the hypothesis that in myocytes parkin has dual properties in the maintenance of skeletal muscle mitochondrial homeostasis and in the regulation of Abeta levels.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. A. Rodriguez-Navarro, A. Gomez, I. Rodal, J. Perucho, A. Martinez, V. Furio, I. Ampuero, M. J. Casarejos, R. M. Solano, J. G. de Yebenes, et al.
Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice
Hum. Mol. Genet., October 15, 2008; 17(20): 3128 - 3143.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Klein and M. G. Schlossmacher
Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Neurology, November 27, 2007; 69(22): 2093 - 2104.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al.
Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling
J. Neurosci., February 21, 2007; 27(8): 1868 - 1878.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement